1[1]Executive summary of the guidelines on the diagnosis and treatment of acute heart failure,the Task Force on Acute Heart Failure of the European Society of Cardiology.Eur Heart J,2005,26:384-416.
2[23]Wendy GS,Christopher MO,Mihai G.Overview of current noninodilator therapies for acute heart failure syndromes.Am J Cardiol,2005,96(Suppl):41G-46G.
3[3]Gad C,Yaron M,Olga M,et al.Acute heart failure:a novel approach to its pathogenesis and treatment.Eur J Heart Fail,2002,4:227-234.
7[7]Elkayam U,Bitra F,Akhter MW,et al.Intravenous nitroglycerin in the treatment of decompensated heart failure:potential benefits and limitations.J Cardiovasc Pharmacol Ther,2004,9:227-241.
5Li J, Li W, Altura BT, Altura BM. Peroxynitdte-induced relaxation in isolated rat aortic rings and mechanisms of action. Toxicol Appl Pharmacol, 2005, 209(3): 269-276.
6Kranke P,Eberhart LH,Roewer N,et al.Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering:a quantitative systematic review of randomized controlled trials.Anesth Analg,2004,99(3):718.
7Stangl K,Dschietzig T,Richter C,et al.Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure:acute effects of vasodilator therapy.Circulation,2000,102(10):1132.
10PAIK H D,PARK J S,PARK E. Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet[J].Biological and Pharmaceutical Bulletin,2005,(07):1270-1274.
